Davis Todd C Insider Trades

Insider Trading History

Track insider trading activity for Davis Todd C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Palvella Therapeutics
Palvella Therapeutics PVLA
Director
Holding Value $449k 3,000 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 3,000 shares
$102.19
$149.68
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $60M 199,381 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.3M 60,553 shares
$202.55
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $59M 195,946 shares
Last Trade
Feb 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.67M 9,099 shares
$183.83
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $64.3M 213,585 shares
Last Trade
Feb 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1M 60,426 shares
$183.83
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $59.6M 197,985 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.37M 23,778 shares
$183.83
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $48.6M 161,337 shares
Last Trade
Dec 04, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$24.5k 130 shares
$188.50
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $48.6M 161,467 shares
Last Trade
Jun 30, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$26.5k 233 shares
$113.68
$300.97
Palvella Therapeutics
Palvella Therapeutics PVLA
Director
Holding Value $1.85M 12,350 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 12,350 shares
$26.23
$149.68
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $48.5M 161,234 shares
Last Trade
May 09, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1M 9,510 shares
$105.20
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $45.7M 151,724 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8M 93,476 shares
$115.26
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $40.5M 134,597 shares
Last Trade
Feb 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$778k 6,486 shares
$120.00
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $41.2M 136,828 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$836k 6,966 shares
$120.00
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $43.3M 143,794 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.49M 20,784 shares
$120.00
$300.97
Palvella Therapeutics
Palvella Therapeutics PVLA
Director
Holding Value $16.8M 112,547 shares
Last Trade
Dec 13, 2024 Sale
No data
No data
$149.68
Palvella Therapeutics
Palvella Therapeutics PVLA
Director
Holding Value $3.7M 24,700 shares
Last Trade
Dec 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$149.68
Chromocell Therapeutics
Chromocell Therapeutics CHRO
Director
Holding Value $355k 263,306 shares
Last Trade
Nov 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 49,605 shares
$6.41
$1.35
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $37M 123,010 shares
Last Trade
Aug 08, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$243k 2,500 shares
$97.39
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $36.3M 120,510 shares
Last Trade
Jun 28, 2024 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$29.5k 350 shares
$84.26
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $36.2M 120,160 shares
Last Trade
Mar 25, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 16,015 shares
$69.25
$300.97
Ligand Pharmaceuticals
Ligand Pharmaceuticals LGND
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 25, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 16,015 shares
$69.25
$300.97

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up